|
Use in congenital diaphragmatic hernia
|
| bet | 637/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Use in congenital diaphragmatic hernia: In a case series of 13 infants with CDH treated with argipressin for refractory hypotension, argipressin (range 0.0001–0.002 units/kg/min) increased mean arterial pressure and decreased pulmonary/systemic pressure ratio, heart rate, and fraction of inspired oxygen. In 6 of 13 patients, extracorporeal membrane oxygenation therapy was no longer indicated after treatment. The role of argipressin in newborns with CDH and refractory hypotension is unclear. (LOE IV, GOR D) 7, 8
|
| |
